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patients is at the highest risk of developing signiﬁcant problems
that would require hospitalization. Despite this high risk, the use of
PBSC with higher-than-average CD34 counts, the predictability
and consistency of engraftment, and the use of once-daily broad-
spectrum antibiotics facilitates outpatient care delivery. A total of
279 malignant hematology patients (53% NHL, 32% MM, 15%
HD) who underwent autologous HSCT over the last 5 years were
reviewed for evaluation of the safety of this outpatient program. In
this group, 63% were male and 37% female, and the average age
was 47 years (range, 13–68 years). The average LOS was 11.3 days
as an outpatient and 12.4 as an inpatient. Eight patients were
admitted to ICU from the outpatient program within 24 hours,
with 1 death. Common complications were related to febrile neu-
tropenia or bacteremia. This presentation will outline the inter-
ventions used by nurses in the program to maintain safe and
effective patient care in the outpatient setting.
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INFECTION IN THE PEDIATRIC PATIENT AFTER BONE MARROW OR
STEM CELL TRANSPLANTATION: NURSING CONSIDERATIONS
Kokoszka, A.K., Frey, M.A., Talbert, G., Martin, P.L. Duke University
Medical Center, Durham, NC.
Infection remains the leading cause of death in pediatric patients
undergoing bone marrow or stem cell transplantation despite new
medications and treatment modalities. Diagnosis of these infec-
tions has become easier due to newer diagnostic technologies.
Treatment options for these patients have also greatly improved,
primarily related to earlier detection and implementation of ap-
propriate drug therapies. Risk factors for life-threatening infec-
tions include, but are not limited to, increased numbers of unre-
lated transplantations with subsequent prolonged periods of
aplasia. The prolonged period of aplasia often places the patient at
a higher risk of acquiring multiple infections as the same time.
Bacterial, viral, and fungal infections can occur at any time during
the transplantation trajectory. However, due to the engraftment of
different infection-ﬁghting cells at different points in the timeline,
certain infections are more likely to occur at certain (predicted)
periods during the course of transplantation. Early detection and
treatment offer the patient the best options for treatment and
eradication of the infecting organism.
The purpose of this abstract is to describe the common infections
associated with bone marrow and stem cell transplantation. The
established guidelines for early detection and intervention will be
discussed, as will the “gold standard” for treatment of these organisms.
Nursing considerations related to the prevention, diagnosis, and treat-
ment of these diseases will be discussed. A timeline for when the
prevalent organisms are likely to occur will also be shared. Finally, a
guide for the prevention of nosocomial infections will be presented.
Nosocomial transmission of infections remain an all-too-common,
but avoidable, occurrence. Heightened awareness of infection control
practices can greatly reduce the risks of hospital-acquired infections.
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MENTORING: “BRIDGING THE GAP” FOR TRANSPLANTATION COOR-
DINATORS IN ONE OF THE LARGEST TRANSPLANTATION PROGRAMS
IN THE COUNTRY
Stary, S.J., Zabawa, S., Calamusa, J., Adornetto, D.L. University of
Texas M.D. Anderson Cancer Center, Houston, TX.
Mentoring a clinical nurse to the complex role of the blood and
marrow transplantation (BMT) coordinator requires assessment of
the nurse’s skills and knowledge base to formulate an orientation
plan that bridges the gap into the evolution of a BMT coordinator.
Orientation includes the complexity of the patients’ needs, re-
search protocols, team building, communication/organizational
skills, and the organizational/operational needs of the program and
center.
Currently, the BMT Center employs 5 coordinators, with vary-
ing work backgrounds, who are each responsible for the coordina-
tion of pretransplantation care of patients for 2 or 3 physicians.
Therefore, the orientation process must be tailored to the new
employee’s individual needs as well as the needs of the program
and center. In 2003 a BMT orientation manual was developed for
the existing coordinator group; however, with an inﬂux of new staff
members, it was found to be confusing for staff who are inexperi-
enced in BMT. Through the process of orienting new staff mem-
bers, the orientation manual was expanded to encompass basic
oncology as well as BMT-related information. Computer skills
required for communication among the multidisciplinary care
team, and sample orders to meet policy and procedures within the
BMT Center, were also incorporated. New employees to the
coordinator role are assessed for their oncology/BMT knowledge
bas, by reviewing prior experience and quizzing them on their
knowledge. They are also supplemented with additional course
work to improve knowledge base. Each novice staff member is
paired with an experienced BMT coordinator for a period of 2–3
weeks after basic knowledge base and computer/communication
skills are attained. On completion of orientation, the “coordinator
orientation checklist” is completed and placed in the employee ﬁle.
Through the use of the expanded orientation manual and the
mentoring from experienced coordinators, the novice coordinator
is better prepared to work effectively in the coordinator role.
Likewise, with continued mentoring, education, applicable in-ser-
vices, and the manual as a resource, they are able to work inde-
pendently to facilitate seamless care for the transplantation patient.
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QUALITY IMPROVEMENT: A TRULY INTERDISCIPLINARY APPROACH
Sorensen, S.H., Adornetto, D.L. University of Texas M.D. Anderson
Cancer Center, Houston, TX.
Patient satisfaction surveys are distributed monthly in the Blood
and Marrow Transplantation Clinic at our center. The results of
these surveys led the clinic management team to identify the
following problems: clinic wait times, missed appointments, unan-
swered telephones, and unanswered voice mail messages. Process
improvement teams had been identiﬁed to work through the prob-
lem list using the “plan, do, check, act” methodology. Progress was
discussed at the weekly operations meeting attended by managers
and updates were provided at faculty meetings. These items were
also discussed at staff center wide meetings, and e-mails were sent
announcing any changes being made. Although every effort was
made to inform personnel, the challenge facing the management
team was to ensure that the entire BMT clinic staff knew what was
being done to improve these processes. An interdisciplinary BMT
Clinic quality improvement team was established to facilitate an
exchange of ideas and obtain faculty input. Members of the faculty
and representatives of all clinic work groups met to discuss the
issues and what had been done thus far. The problems were
prioritized, and new working groups that included faculty members
were formed to address these problems. The staff were asked to
write incident reports for anything that did not go as planned;
these were used to trend issues and identify new problems. This
information was taken to the clinic QI group, and priorities were
changed to address any pertinent ﬁndings. The result was a team
effort of process improvement with faculty support and input.
Patient satisfaction results, comment cards, and a decline in inci-
dent reports for those problems identiﬁed will be used to measure
any improvement. It is hoped this effort will result in improved
communication and sharing of information throughout the pro-
gram.
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CELEBRATION OF LIFE: THE FIRST BLOOD AND MARROW TRANSPLAN-
TATION SURVIVOR’S DAY AT ONE OF THE LARGEST TRANSPLANTA-
TION CENTERS IN THE COUNTRY
Adornetto, D.L., Denman, C., Bourne, L. University of Texas M.D.
Anderson Cancer Center, Houston, TX.
More than 550 blood and marrow transplantation patients and
their families from a 5-state area attended the ﬁrst M.D. Anderson
BMT Survivor’s Day Celebration on June 13, 2004. Planning for
the celebration started 7 months earlier with a multidisciplinary
team of approximately 25 staff members from both the adult and
pediatric BMT programs. Multiple subcommittees were formed to
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address different aspects of the event, including registration, speak-
ers, food, decorations, communication, parking, arts and crafts,
vendor exhibits, activities, educational sessions, and budget and
funding. The event was a celebration of life for BMT survivors and
was registered with the National Cancer Survivor’s Day Organi-
zation 17th National Observance of Survivors. It was a forum for
survivors to share their experiences and stories and provided an
opportunity to acknowledge the contribution of families, friends,
BMT researchers, and health care providers who are dedicated to
supporting BMT cancer survivors in their ﬁght for life. Our pro-
gram theme was “Survivor’s Island,” with decorations of palm trees
and other island decor. The volunteers and committee members
donned matching mango shirts and greeted the attendees with leis,
goodie bags, and Survivors’ Day t-shirts as they arrived. Attendees
enjoyed popcorn, food, and a cake in their honor. Vendors lined
the hallways with their exhibits. An arts and crafts room provided
the survivors an opportunity to place their special mark on 2
canvases that will forever capture their special day. With the help
of our institution’s Volunteer Endowment for Patient Support
Program, donations from local businesses, and physician and staff
contributions, we were able to provide a fun-ﬁlled program that
concluded with many gifts given away to our guests. With the
endless support of so many, this event recognized our active,
productive BMT survivor population and was the ﬁrst of what we
envision to be an annual celebration for the BMT program.
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ADENOVIRUS INFECTION IN PEDIATRIC BONE MARROW TRANSPLAN-
TATION: NURSING CONSIDERATIONS
Stokyhuzen, A., Frey, M., Prasad, V. The Duke Pediatric Stem Cell
Transplant Program, Durham, NC.
Adenovirus is widely recognized as a signiﬁcant cause of morbid-
ity and mortality in the pediatric bone marrow transplantation
population. Allogeneic and stem cell transplantation are additional
risk factors that negatively impact patient outcomes. Adenovirus is
a common DNA virus that accounts for 5%-10% of pediatric
febrile illnesses. Most children will be infected by one of the
adenovirus serotypes by age 5 years. For the healthy child, symp-
toms are generally mild. In the immunocompromised patient,
infection can range from asymptomatic shedding of the virus to
fatal disease. Mortality in the immunosuppressed host can range
from 50% to 60%. Risk factors attributed to a higher risk of
invasive or disseminated disease are age, allogeneic transplantation,
GVHD, and 2 or more positive culture sites. Adenovirus viremia is
associated with severe disease and can lead to pneumonia, gastro-
enteritis, hepatitis, cystitis, myocarditis, and encephalitis. Diagno-
sis of adenovirus can be made by serology, viral culture, shell viral
culture, electron microscopy, PCR, or immunostain. Treatment
for adenovirus remains variable and is not standardized at present.
Ribavirin, gancyclovir, IVIG therapy, and, most recently, cidofavir
are available as treatment options. The virus is spread easily by
droplets or via the fecal-oral route. Health care professionals,
visitors, and families need the education and diligence to adhere to
all institutional and CDC infection control guidelines. The pur-
pose of this abstract is to (1) describe the pathophysiology of
adenovirus in the immunocompromised host, (2) describe the clin-
ical symptoms of infection and severe disease, (3) outline the
current diagnostic tests used in adenovirus detection, (4) review the
current treatment options for adenovirus, and (5) describe infec-
tion control and nursing practices that are used in the care of these
patients.
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THE SAFE ADMINISTRATION OF UNDILUTED ETOPOSIDE IN THE PE-
DIATRIC BLOOD AND MARROW TRANSPLANTATION PATIENT
Fisher, V.L., Kistler, K., Rowbottom, L., Hegyi, K., Heinrich, M.
Rainbow Babies and Children’s Hospital, Cleveland, OH.
Blood and marrow transplantation (BMT) is successfully used to
treat malignant and nonmalignant diseases and disorders. The
delivery of the preparative regimen requires a strong knowledge
base that includes the expertise in the administration of chemo-
therapy and side effects. We report the administration of undiluted
etoposide (Bedford Laboratories, Bedford, OH) in our transplan-
tation program with minimal complications. In our series of pa-
tients, the decision to use undiluted etoposide was made due to
restrictive ﬂuid parameters and the patient’s condition. We have
used undiluted etoposide in 5 pediatric BMT patients. All patients
had a central venous access device for the administration of the
chemotherapy agent. All patients received their chemotherapy via
a syringe pump. To prevent disintegration of the tubing during the
administration of undiluted etoposide, all patients had a “dry”
connection from the syringe pump to the syringe tubing and to the
CVAD access port. All patients had vital signs taken per our policy
of every 15 minutes for the ﬁrst hour of the infusion, then every 30
minutes for the second hour of the infusion, then hourly until the
infusion was completed, and then every 4 hours. All patients had
emergency medications readily available during the etoposide in-
fusion. All patients received undiluted etoposide as a 4-hour infu-
sion; in 2 of the 5 patients the infusion time was increased due to
grade 2 hypotension, which recovered by temporarily stopping the
infusion. Our experience suggests that undiluted etoposide can be
safely administered in pediatric BMT patients.
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UTILIZING THE TOWN MEETING FORUM TO INVOLVE CAREGIVERS OF
PEDIATRIC PATIENTS UNDERGOING BONE MARROW AND STEM CELL
TRANSPLANTATION
Talbert, G., Frey, M.A. Duke University Medical Center, Durham,
NC.
Caregivers of children undergoing bone marrow and stem cell
transplantation face unique and signiﬁcant challenges. The average
length of stay for patients on the Duke Pediatric Stem Cell Trans-
plantation Unit is often several months. Caregivers are required to
leave their homes and extended families in hope of a life-saving
transplantation for their child. They enter a strange environment
over which they have very little control. Parents often report
feelings of “helplessness” and “being at the mercy of others” during
this difﬁcult period of time.
In 2003 the Duke Pediatric Stem Cell Transplant inpatient unit
developed a weekly Town Meeting Program to address the needs
of caregivers during the inpatient phase of transplantation. Each
week the medical, nursing, and support teams hold a 1-hour in-
formal meeting on the inpatient unit to speciﬁcally address the
needs of the families. These meetings were created to provide a
relaxed forum in which caregivers are free to discuss issues and
make improvements on the unit. Caregivers can voice concerns,
provide positive feedback, and request assistance in problem-solv-
ing. The town meeting also serves as a forum for the clinical team
to share ideas and monitor the overall morale of the caregivers. All
families also receive the services of the social work team for per-
sonal issues and concerns. This forum has greatly improved parent
satisfaction on the unit.
The purpose of this abstract is to share The Duke Pediatric Stem
Cell Transplantation Unit town meeting design with other trans-
plantation centers, including (1) design and implementation of the
initial forum; (2) who, where, and when—which staff to involve,
where to hold meetings and the best time for them; (3) successful
facilitation of the town meeting; and (4) keeping the momentum—
how to keep the meeting fresh and productive.
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EMPOWERING BMT NURSES TO SPEAK UP AND BE HEARD
Rivera, Z.R., Neumann, J.L. University of Texas M.D. Anderson
Cancer Center, Houston, TX.
Treatment with blood and marrow transplantation (BMT) can be
overwhelming, and pretreatment patient expectations can be high.
Caring for BMT patients involves a multidisciplinary approach.
Development of multidisciplinary teams allow for communication
of the treatment plan including medicine, pharmacy, psychosocial,
and rehabilitation aspects of care and discussion of expectations as
the treatment progresses. Having all disciplines involved contrib-
utes to the most beneﬁcial outcome for the patient.
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